Answer to Question 1
4
Rationale: An adverse effect of this medication therapy is agranulocytopenia and anemia. The nurse carefully monitors the CBC for these changes. With early HIV infection or in the client who is asymptomatic, CBC levels are monitored monthly for 3 months, and then every 3 months thereafter. In clients with advanced disease, these levels are monitored every 2 weeks for the first 2 months, and then once a month if the medication is tolerated well. Blood culture, blood glucose level, and blood urea nitrogen level (BUN) are unrelated to this medication.
Answer to Question 2
4
Rationale: If the balloon is malpositioned in the urethra, balloon inflation could cause trauma and pain. If this occurs, the fluid should be aspirated and the catheter inserted a little farther to move the balloon past the neck of the urethra into the bladder. The catheter should not be withdrawn slightly (aspirate the fluid, withdraw the catheter slightly, and reinflate the balloon) because this will worsen the problem. There is no need to remove the catheter and reinsert a smaller one. The balloon should not continue to be inflated because the pain is not normal and will not go away.
The nurse uses a noninvasive bladder ultrasound to measure the client’s bladder volume.
Upper respiratory infection
Diagram of Human Skeleton
The divisions of the adult human brain.
Predicted polypeptide sequences translated from potential ORFs in the human TUBA3C gene
Example of inflammation as a response to bacterial infection.